MA MPJE key terms

The Massachusetts regulatory board within the Department of Public Health that licenses pharmacists, interns, technicians, and pharmacies, adopts pharmacy regulations, investigates complaints, and imposes discipline on licensees.

The body of Massachusetts regulations, Title 247 of the Code of Massachusetts Regulations, that sets detailed rules for pharmacy licensure, practice, dispensing, recordkeeping, and facility standards.

A Board-issued credential allowing a student enrolled in an accredited pharmacy program to practice under a licensed pharmacist's supervision; registration is required before the student accrues practical experience hours.

A Board-issued credential required for support personnel who assist pharmacists with dispensing and related tasks; technicians work under pharmacist supervision and may not perform duties reserved to pharmacists.

Massachusetts pharmacist and technician credentials renew on a two-year cycle and require completion of a set number of continuing education hours, including any topics the Board specifies, attested to at renewal.

A pharmacy must hold a current Board license for its physical location before dispensing; the license is tied to the address, ownership, and pharmacist-in-charge and must be displayed at the site.

A written arrangement in which a prescriber authorizes a pharmacist to assess patients and initiate, modify, or discontinue drug therapy under defined protocols; the agreement must be documented and available to the Board.

Massachusetts pharmacists may administer specified vaccines to patients within Board-set age limits after completing accredited immunization training and holding current CPR certification, and must document and report each dose.

The statewide immunization registry; pharmacists who administer vaccines must report the doses given and may query the registry to review a patient's prior immunization history.

A statewide protocol allowing pharmacists to dispense naloxone without a patient-specific prescription, with education on overdose response, to anyone at risk of opioid overdose or in a position to help.

A valid prescription must show the patient's name, drug, strength, dosage form, quantity, directions, date, and prescriber information; Schedule VI orders may be taken orally but must be promptly reduced to writing.

Dispensing a less expensive therapeutically equivalent product in place of the prescribed brand unless the prescriber prohibits substitution or the patient objects; the patient must be told of the substitution.

A prescriber's written direction on the prescription that the brand-name drug be dispensed as written, which bars the pharmacist from substituting a therapeutically equivalent generic product.

Required label content includes the pharmacy name and address, prescription number, date, patient name, directions for use, prescriber, drug name and strength, quantity, and any required cautionary statements on the container.

Massachusetts requires prescriptions, including controlled substances, to be transmitted electronically, subject to limited statutory exceptions such as system failure or a prescriber's approved hardship waiver.

The state controlled substances registration issued by the Department of Public Health; prescribers and dispensers need it in addition to a DEA registration, and it is renewed every three years.

Federal registration authorizing a practitioner or pharmacy to handle controlled substances; it is site-specific, must be renewed every three years, and must be obtained before the corresponding state authority.

The state database of controlled substance dispensings; dispensers submit data by the close of the next business day, and pharmacists query it before dispensing specified Schedule II and III narcotics.

Schedule II prescriptions cannot be refilled, must be written or electronic, and an emergency oral order requires the prescriber to deliver a written prescription within seven days.

Pharmacies must take an initial and biennial inventory of controlled substances, keep receipts and dispensing records for at least two years, and store the drugs securely under required safeguards.

The licensed pharmacist designated to the Board as responsible for a pharmacy's day-to-day compliance with licensing, security, recordkeeping, and dispensing rules; changes in this role must be reported.

The area where prescriptions are prepared must be clearly defined, secured against public access, equipped as required, and locked when no pharmacist is present on the premises.

Prescription and dispensing records must be kept at the pharmacy and be retrievable for Board inspection for at least two years, or longer where controlled substance or other rules require.

The Board inspects pharmacies before initial licensure and periodically thereafter to verify compliance with facility, equipment, security, and recordkeeping standards; identified deficiencies must be corrected.

National standards for sterile compounding that govern cleanroom design, environmental monitoring, personnel training and garbing, and the assignment of beyond-use dates to prepared sterile products.

National standards for handling hazardous drugs, covering containment, ventilation, personal protective equipment, deactivation and decontamination, and training for anyone who handles these drugs.

Federal law creating an interoperable, serialized drug supply chain; pharmacies may accept product only with valid transaction information and must quarantine and investigate suspect or illegitimate product.

A license issued by the Board authorizing a business to distribute drugs to Massachusetts pharmacies; out-of-state distributors must also be licensed and comply with recordkeeping and transaction documentation rules.

The pharmacist's duty to personally offer counseling on new prescriptions, and on refills when requested, covering directions, side effects, and storage, with the encounter documented in the patient record.

A profile maintained for each patient listing prescriptions, known allergies, and clinical information used to screen for interactions, duplicative therapy, and other safety problems before dispensing.

Pharmacies must maintain a written program to detect, analyze, and prevent medication errors and must report defined quality-related events to the Board as required by regulation.

The Board may deny, suspend, revoke, or restrict a license for causes that include incompetence, fraud, dispensing errors that endanger patients, impairment, and violation of pharmacy law.

Conduct barred by statute and regulation, such as dispensing without a valid prescription, falsifying records, practicing while impaired, and letting unlicensed persons perform pharmacist-only functions.

Licensees must notify the Board within a set time after certain events, such as criminal convictions, discipline imposed by another state, or changes affecting their ability to practice safely.